Cite
APA Citation
Price, T., Kim, T., Li, J., Cascinu, S., Ruff, P., Suresh, A., Thomas, A., Tjulandin, S., Guan, X., Hoang, T., Hei, Y., & Peeters, M. (n.d.). 2110 Efficacy outcomes by severity of skin toxicity from ASPECCT: Randomized phase 3 study of panitumumab (pmab) versus cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC). European journal of cancer, 51, S366–. http://access.bl.uk/ark:/81055/vdc_100030628213.0x000024